A designer cell culture insert with a nanofibrous membrane toward engineering an epithelial tissue model validated by cellular nanomechanics. Issue 16 (29th July 2021)

• Record Type: Journal Article
• Authors: Kumar, Prasoon; Kedaria, Dhaval; Mahapatra, Chinmaya; Mohandas, Monisha; Chatterjee, Kaushik
• Is Part Of: Nanoscale advances. Volume 3:Issue 16(2021)
• Page Start: 4714
• Page End: 4725
• Publication Date: 2021-07-29
• Subjects: 620.5
• DOI: 10.1039/d1na00280e
• Languages: English
• ISSNs: 2516-0230

Abstract

Abstract : A designer insert was fabricated with nanofibrous membrane as a culture platform for cells of the skin and other epithelial tissues that can be useful as in vitro tissue model and for drug screening applications. Abstract : Engineered platforms for culturing cells of the skin and other epithelial tissues are useful for the regeneration and development of in vitro tissue models used in drug screening. Recapitulating the biomechanical behavior of the cells is one of the important hallmarks of successful tissue generation on these platforms. The biomechanical behavior of cells profoundly affects the physiological functions of the generated tissue. In this work, a designer nanofibrous cell culture insert (NCCI) device was developed, consisting of a free-hanging polymeric nanofibrous membrane. The free-hanging nanofibrous membrane has a well-tailored architecture, stiffness, and topography to better mimic the extracellular matrix of any soft tissue than conventional, flat tissue culture polystyrene (TCPS) surfaces. Human keratinocytes (HaCaT cells) cultured on the designer NCCIs exhibited a 3D tissue-like phenotype compared to the cells cultured on TCPS. Furthermore, the biomechanical characterization by bio-atomic force microscopy (Bio-AFM) revealed a markedly altered cellular morphology and stiffness of the cellular cytoplasm, nucleus, and cell–cell junctions. The nuclear and cytoplasmic moduli were reduced, while the stiffness of the cellular junctions was enhanced on the NCCI compared to cells on TCPS, which are indicative of the fluidic state and migratory phenotype on the NCCI. These observations were corroborated by immunostaining, which revealed enhanced cell–cell contact along with a higher expression of junction proteins and enhanced migration in a wound-healing assay. Taken together, these results underscore the role of the novel designer NCCI device as an in vitro platform for epithelial cells with several potential applications, including drug testing, disease modeling, and tissue regeneration.